|
|
Volumn 285, Issue 10, 2001, Pages 1279-1281
|
|
20 Years after AIDS emerges, HIV's complexities still loom large
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
CHEMOKINE RECEPTOR CCR5;
DAPIVIRINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STEROL REGULATORY ELEMENT BINDING PROTEIN;
T 1249;
TMC 126;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BINDING SITE;
DRUG EFFICACY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE;
HUMAN TISSUE;
META ANALYSIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SIDE EFFECT;
STRAIN DIFFERENCE;
VIRUS MUTATION;
VIRUS RESISTANCE;
VIRUS TRANSMISSION;
|
|
EID: 0035857777
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.285.10.1279 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|